Growth Metrics

Mannkind (MNKD) Share-based Compensation (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.42%
Dec 31, 2025 61.46%
Sep 30, 2025 -42.58%
Jun 30, 2025 39.65%
Mar 31, 2025 -7.44%
Dec 31, 2024 11.31%
Sep 30, 2024 -18.68%
Jun 30, 2024 65.46%
Mar 31, 2024 1.89%
Dec 31, 2023 -17.13%
Sep 30, 2023 -17.54%
Jun 30, 2023 52.67%
Mar 31, 2023 40.74%
Dec 31, 2022 -28.30%
Sep 30, 2022 -18.09%
Jun 30, 2022 57.59%
Mar 31, 2022 -11.20%
Dec 31, 2021 -0.60%
Sep 30, 2021 -19.03%
Jun 30, 2021 102.89%
Mar 31, 2021 1.63%
Dec 31, 2020 47.14%
Sep 30, 2020 -40.78%
Jun 30, 2020 93.71%
Mar 31, 2020 26.60%
Dec 31, 2019 -45.67%
Sep 30, 2019 -36.14%
Jun 30, 2019 157.06%
Mar 31, 2019 -12.52%
Dec 31, 2018 -26.89%
Sep 30, 2018 -29.29%
Jun 30, 2018 13.69%
Mar 31, 2018 79.24%
Dec 31, 2017 -13.07%
Sep 30, 2017 -0.24%
Jun 30, 2017 -1.34%
Mar 31, 2017 26.07%
Dec 31, 2016 -33.09%
Sep 30, 2016 10.85%
Jun 30, 2016 4.23%
Mar 31, 2016 -44.61%
Dec 31, 2015 -9.73%
Sep 30, 2015 46.48%
Jun 30, 2015 -11.38%
Mar 31, 2015 7.28%
Dec 31, 2014 138.68%
Sep 30, 2014 -111.88%
Jun 30, 2014 681.62%
Mar 31, 2014 -62.54%
Dec 31, 2013 -12.93%
Sep 30, 2013 56.73%
Jun 30, 2013 96.03%
Mar 31, 2013 47.33%
Dec 31, 2012 -7.80%
Sep 30, 2012 24.35%
Jun 30, 2012 6.74%
Mar 31, 2012 -9.53%
Dec 31, 2011 -4.24%
Sep 30, 2011 66.68%
Jun 30, 2011 -26.40%
Mar 31, 2011 21.05%
Dec 31, 2010 -32.98%